Learn how AbbVie and Ironwood can help you save on LINZESS. Call 1-855-226-3937 or click to LEARN MORE ▸

Skip to Main content
  • Prescribing Information
  • Medication Guide
  • Healthcare Professionals
Linzess logo
  • En Español
  • Cost & Savings
  • WHY LINZESS
    • How LINZESS Can Help
    • How LINZESS Works
    • Side Effects of LINZESS
    • LINZESS Patient Experiences
  • UNDERSTANDING CONSTIPATION
    • Types of Constipation
    • What is IBS-C
    • What is CIC
    • Constipation Treatment Options
    • Tips for Managing Constipation
    • Pediatric Functional Constipation
  • FIND RELIEF
    • Talk to a Doctor
    • Check My Symptoms
    • How to Take LINZESS
  • STARTING LINZESS
    • LINZESS Savings Program
    • Healthy Routines
    • Wellness Tips
    • Community Resources
    • Sign Up for Support
    • FAQs
  • CHECK MY SYMPTOMS
  • GET SAVINGS NOW
  • HEALTHCARE PROFESSIONALS
  • COST & SAVINGS
  • EN ESPAÑOL
CHECK MY SYMPTOMS
TALK TO A DOCTOR ONLINE
CHECK MY SYMPTOMS

SITEMAP

WHY LINZESS

How LINZESS Can Help

How LINZESS Works

Side Effects of LINZESS

LINZESS Patient Experiences

UNDERSTANDING CONSTIPATION

Types of Constipation

What Is IBS-C

What Is CIC

Pediatric Functional Constipation

Constipation Treatment Options

Tips for Managing Constipation

FIND RELIEF

Talk to a Doctor

Check My Symptoms

How to Take LINZESS

STARTING LINZESS

LINZESS Savings Program

Savings Card

Healthy Routines

OTC & Prescription Treatments

Tackling IBS-C Triggers

Keeping in Touch with Your Doctor

Wellness Tips

Your Map to a Low FODMAP Diet

Good for Your Gut-Flavorful Food Swaps

Make a Game Plan for IBS-C

5 Holiday Low FODMAP Recipes

Is Your Pantry FODMAP-Friendly?

Community Resources

Sign Up for Support

FAQs

Cost & Savings

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt). 
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if LINZESS will harm your unborn baby.
  • Breastfeeding or plan to breastfeed. You and your doctor should decide if you will take LINZESS and breastfeed.


Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.


Side Effects

LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.

Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).

Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.

These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist. 

Please see full Prescribing Information, including Boxed Warning, and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

US-LIN-250020

WHY LINZESS
  • How LINZESS Can Help
  • How LINZESS Works
  • Side Effects of LINZESS
  • LINZESS Patient Experiences
UNDERSTANDING CONSTIPATION
  • Types of Constipation
  • What Is IBS-C
  • What Is CIC
  • Pediatric Functional Constipation
  • Constipation Treatment Options
  • Tips for Managing Constipation
FIND RELIEF
  • Talk to a Doctor
  • Check My Symptoms
  • How to Take LINZESS
STARTING LINZESS
  • LINZESS Savings Program
  • Healthy Routines
  • Wellness Tips
  • Community Resources
  • Sign Up for Support
  • FAQs
  • Ironwood California Privacy Policy
  • Accessibility Statement
  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Consumer Health Data Privacy Notice
  • Cookies Settings
  • Your Privacy Choices
  • Sitemap

AbbVie® and its design are trademarks of AbbVie Inc.
Ironwood® and its three-leaf design are registered trademarks of Ironwood Pharmaceuticals, Inc. LINZESS® and its design are registered trademarks of Ironwood Pharmaceuticals, Inc. From the Gut℠ is a service mark of Allergan Sales, LLC, an AbbVie company.

The product information provided in this site is intended only for residents of the United States. The products discussed on this site may have different product labeling outside of the United States. The health information described in this site is provided for educational purposes only and is not intended to substitute for discussions with a healthcare provider.


  • Abbvie logo
  • Ironwood logo
  • © 2024 AbbVie and Ironwood Pharmaceuticals, Inc. All rights reserved. 

↑ Back to top

US-LIN-250001

Linzess logo

For Healthcare Professionals

This information provided on this website is intended for U.S. healthcare professionals only.

I certify that I am a U.S. Healthcare Professional.

No
YES

For adults with Irritable Bowel Syndrome with Constipation (IBS-C) or Chronic Idiopathic Constipation (CIC)

TALK TO A DOCTOR ONLINE TODAY*

Answer a few quick questions about your symptoms.

Connect with a doctor online to find out if it could be IBS-C or CIC.

If approved, pick up your prescription from your local pharmacy.

*Third-party website; does not constitute an endorsement or recommendation by AbbVie. A fee will be charged by the telemedicine provider.

Acknowledge and Continue
Cancel

You are now leaving LINZESS.com

By clicking “Acknowledge and Continue” above, you acknowledge and agree that neither AbbVie nor Ironwood does, in any way, endorse or recommend UpScript, a telemedicine provider, the qualifications of any physician associated with UpScript, or the quality of medical care any of those physicians can provide. You also acknowledge and agree that neither AbbVie nor Ironwood makes any guarantees that using UpScript will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie and Ironwood recommend that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE, IRONWOOD, AND THEIR RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE UPSCRIPT WEBSITE. If you agree to the above, click “Acknowledge and Continue” to proceed to the UpScript website. If you do not agree to the above, click “Cancel” to remain on LINZESS.com.

TALK TO A DOCTOR ONLINE

Did you know you can talk to a doctor today from the comfort of your home? Connect with a healthcare professional online about your symptoms.

NO THANKS
GET STARTED

YOU ARE NOW LEAVING LINZESS.COM

Links to other websites are provided as a service to you. AbbVie and Ironwood Pharmaceuticals accept no responsibility for the content of other websites.

Would you like to continue?

No
Yes

YOU ARE NOW LEAVING LINZESS.COM

Links to third-party content are provided as a convenience for informational purposes only. They are not meant to replace your healthcare provider’s medical advice or treatment. The organizations listed have not endorsed AbbVie and Ironwood or any of their respective products or services. AbbVie and Ironwood have listed these sites only as a convenience and according to the permissions granted by their respective terms of use. Each organization has its own terms and conditions and privacy policy that you should read if you choose to contact any of them.

Would you like to continue?

No
Yes

Transcript

Share

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

You are leaving an AbbVie hosted website.

You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the content of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.​

Conversely, the presence of this link does not imply the linked site’s endorsement of AbbVie.

​Do you wish to leave this site?​

No
Yes

US-LIN-230431-WOL

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).

USES

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.

IMPORTANT RISK INFORMATION

  • Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt). 
  • Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if LINZESS will harm your unborn baby.
  • Breastfeeding or plan to breastfeed. You and your doctor should decide if you will take LINZESS and breastfeed.


Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.


Side Effects

LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.

Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).

Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.

These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist. 

Please see full Prescribing Information, including Boxed Warning, and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

US-LIN-250020